Identification of a novel PANoptosis-related gene signature for predicting the prognosis in clear cell renal cell carcinoma

被引:0
|
作者
Yue, Dezhi [1 ]
Ren, Congzhe [1 ]
Li, Hu [2 ]
Liu, Xiaoqiang [1 ]
机构
[1] Tianjin Med Univ, Gen Hosp, Dept Urol, Tianjin 300000, Peoples R China
[2] Shanxian Cent Hosp, Dept Urol, Heze, Shandong, Peoples R China
关键词
clear cell renal cell carcinoma; nomogram; PANoptosis; risk score; signature; CANCER; NECROPTOSIS; APOPTOSIS; PROLIFERATION; INFLAMMASOME; PYROPTOSIS; CASPASE-8;
D O I
10.1097/MD.0000000000039874
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PANoptosis has been shown to play an important role in tumorigenesis and gain more attention. Yet, the prognostic significance of PANoptosis-related genes has not been investigated more in clear cell renal cell carcinoma (ccRCC). The aim of this research was designed to identify and create a signature of PANoptosis-related genes which was expected to predict prognosis of ccRCC more effectively. The transcriptome data and clinical information were collected from The Cancer Genome Atlas database and the Gene Expression Omnibus database. Optimal differentially expressed PANoptosis-related genes, which were closely associated with prognosis and employed to construct a risk score, were extracted by univariate Cox analysis, least absolute shrinkage and selection operator Cox regression and multivariate Cox analysis. We performed Kaplan-Meier survival analysis and time-dependent receiver operating characteristic curves to complete this process. By adopting univariate and multivariate analysis, the constructed risk score was assessed to verify whether it could be taken as an independent contributor for prognosis. Moreover, we created a nomogram in order to predict overall survival (OS) of ccRCC. Five differentially expressed PANoptosis-related genes were screened out and used to construct a risk score. Our results showed that ccRCC patients with high risk score had a poor prognosis and shorter OS. The results of Kaplan-Meier curves and the area under the receiver operating characteristic curves of 1-, 3-, and 5-year OS indicated that the prediction performance was satisfactory. Additionally, the risk model could be taken as an independent prognostic factor in training and validation cohorts. The nomogram exhibited excellent reliability in predicting OS, which was validated by calibration curves. We identified 5 PANoptosis-related genes, which were used to construct a risk score and a nomogram for prognostic prediction with reliable predictive capability. The present study may provide new potential therapeutic targets and precise treatment strategies for ccRCC.
引用
收藏
页数:15
相关论文
共 50 条
  • [11] Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma
    Zhansheng Jiang
    Jiahe Wang
    Chenghuan Dao
    Mingyu Zhu
    Yuan Li
    Fangchao Liu
    Yangyang Zhao
    Jiayue Li
    Yinli Yang
    Zhanyu Pan
    Apoptosis, 2024, 29 : 681 - 692
  • [12] Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma
    Zhu, Jinfeng
    Huang, Qian
    Peng, Xingyu
    Luo, Chen
    Liu, Zitao
    Liu, Dongdong
    Yuan, Huazhao
    Yuan, Rongfa
    Cheng, Xuexin
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [13] Identification of a Glucose Metabolism-related Signature for prediction of Clinical Prognosis in Clear Cell Renal Cell Carcinoma
    Wang, Sheng
    Zhang, Ling
    Yu, Zhihong
    Chai, Kequn
    Chen, Jiabin
    JOURNAL OF CANCER, 2020, 11 (17): : 4996 - 5006
  • [14] Identification and validation of PANoptosis-related LncRNAs prognosis system in hepatocellular carcinoma
    Shu, Qi
    Zhu, Junfeng
    Mo, Jiaping
    Wei, Xiaoyan
    Zhu, Zhenjie
    Chen, Xiaojuan
    He, Fugen
    Zhong, Like
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [15] Construction and validation of a PANoptosis-related lncRNA signature for predicting prognosis and targeted drug response in thyroid cancer
    Li, Ruowen
    Zhao, Mingjian
    Sun, Min
    Miao, Chengxu
    Lu, Jinghui
    PEERJ, 2023, 11
  • [16] Novel amino acid metabolism-related gene signature to predict prognosis in clear cell renal cell carcinoma
    Cheng, Xiaofeng
    Deng, Wen
    Zhang, Zhicheng
    Zeng, Zhenhao
    Liu, Yifu
    Zhou, Xiaochen
    Zhang, Cheng
    Wang, Gongxian
    FRONTIERS IN GENETICS, 2022, 13
  • [17] Identification of a PANoptosis-related Gene Signature for Predicting the Prognosis, Tumor Microenvironment and Therapy Response in Breast Cancer
    Yu, Tianshui
    Cheng, Weilun
    Zhang, Jiarui
    Wang, Ting
    Liu, Yansong
    Duan, Yunqiang
    Hu, Anbang
    Feng, Jianyuan
    Li, Mingcui
    Li, Yanling
    Zhang, Hanyu
    Rong, Zhiyuan
    Shang, Yuhang
    Shakila, Suborna S.
    Ma, Fei
    Guo, Baoliang
    JOURNAL OF CANCER, 2024, 15 (02): : 428 - 443
  • [18] Development and validation of a novel anoikis-related gene signature in clear cell renal cell carcinoma
    Wu, Qihang
    Sun, Yuxiang
    Qin, Xiangcheng
    Li, Maomao
    Huang, Shuaishuai
    Wang, Xue
    Weng, Guobin
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [19] Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma
    Zhang, Yue
    Zhuang, Tongtian
    Xin, Zhenlong
    Sun, Changjian
    Li, Deyang
    Ma, Nan
    Wang, Xiaoyan
    Wang, Xuning
    CELLS, 2023, 12 (01)
  • [20] Identification and validation of a gap junction protein related signature for predicting the prognosis of renal clear cell carcinoma
    Huang, Yongsheng
    Guo, Wenyi
    Zeng, Yuan
    Wang, Xinrong
    Fan, Bohao
    Zhang, Ying
    Yan, Lei
    Gu, Gangli
    Liu, Zhao
    FRONTIERS IN ONCOLOGY, 2024, 14